OwlTail

Cover image of The Psychedelic Therapy Podcast

The Psychedelic Therapy Podcast

A weekly conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts. Presented by Maya, the psychedelic therapy intelligence platform and hosted by Eamon Armstrong.

Weekly hand curated podcast episodes for learning

Popular episodes

All episodes

Read more

A weekly conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts. Presented by Maya, the psychedelic therapy intelligence platform and hosted by Eamon Armstrong.

Lyle Maxson (SoundSelf): Will Digital Therapeutics Replace Psychedelics?

Podcast cover
Read more

The world of digital therapeutics is booming just as fast as psychedelic therapy. Today’s guest, Lyle Maxson, is resolutely optimistic about the positive synthesis of the two.

On the show, we discuss the science of Lyle’s software SoundSelf, which uses voice to generate a hypnotic world of light, color, and sound. We review his business partner Robin Arnott’s Technodelic Manifesto and ask the important question: Will technology replace therapists? We also cover data sovereignty, metric tracking, and finally the future of psychedelic medicine and digital therapeutics.

With a start in immersive environments at festivals, Lyle Maxson is a pioneer of Transformative Entertainment. He is Chief Strategy Officer of Entheo Digital - a digital therapeutics company pursuing FDA clearance and the creation of a wellness technology marketplace at the intersection of psychedelic therapy and experiential medicine. He is also the co-founder of Andromeda Entertainment, a VR publisher bringing to market “Games for Good,” and GeniusX, a VR education platform.

Links

Timestamps

  • :09 - Lyle’s background in lucid dreaming, festival production and biohacking
  • :18 - The Technodelic Manifesto By Robin Arnott
  • :23 - The Science of SoundSelf
  • :28 - Will technology replace therapists?
  • :33 - Metric tracking and data sovereignty
  • :38 - The future of psychedelic medicine and unforeseen consequences of digital therapeutics
  • :46 - Educating psychedelic therapists in VR

Jul 16 2021

55mins

Play

Lisa Dannen (Maya): Our Colleague’s First Ayahuasca Retreat

Podcast cover
Read more

Lisa Dannen, our colleague at Maya, recently experienced her first Ayahuasca retreat in Peru. Today on the show, she shares all the preparation and integration that went into her experience.

On the podcast, we discuss about Lisa’s work with Maya, and why she wanted to experience Ayahuasca for healing and personal growth. We discuss her 10 day experience in the Sacred Valley of Peru as well as her subsequent integration. Finally Lisa gives her advice to others planning a similar experience.

Lisa has over ten years of experience changing what people know, think, and do about controversial social issues, Lisa began her career at the Colorado Coalition for the Homeless, advocating for the housing rights of low-income individuals. In 2015, Lisa transitioned into the cannabis industry to help to reform discriminatory federal and state drug policies as the Marketing Director at the National Cannabis Industry Association in Denver. She currently serves as Maya’s Director of Marketing & Communications and as a passionate proponent for psychedelic healing.

Links

Timestamps

  • :07 - Why Lisa decided to work at a psychedelic medicine company
  • :13 - Why Lisa wanted to drink Ayahuasca and how she prepared
  • :25 - The experience of five ayahuasca ceremonies in ten days
  • :36 - Lisa’s experience with psychedelic integration
  • :42 - How her ayahuasca ceremony has changed Lisa’s professional life
  • :50 - Advice to others planning to go on an ayahuasca experience

Jul 05 2021

55mins

Play

Martijn Schirp (Synthesis): The Container is More Important than the Medicine

Podcast cover
Read more

Building a psychedelic company is a lot like creating a healing container. It starts with really understand your own role as Martijn Schirp, founder of Synthesis — a psilocybin retreat center and institute in the Netherlands — discovered.

On the show we discuss Martijn’s initial roles as facilitator and then CEO of Synthesis and the value of having a comprehensive team. We compare ketamine and psilocybin and the efficacy of a communal setting for healing. We explore creating a safe healing container from medical screening all the way to evidence-based integration. Finally we discuss the stewardship model as the future of psychedelic business.

Synthesis is a legal, professionally guided truffle retreat center for professionals to experience personal growth, emotional breakthroughs, and spiritual development. Their expert team of facilitators and meditation and breathwork instructors, create an experience that blends the best of ancient wisdom, with cutting edge science.

First as CEO and now as Chief Visionary Officer Martijn has driven the vision of Synthesis Institute since he co-founded the company in 2018. He previously co-founded HighExistence and Apotheosis. His work and identity as an entrepreneur is strongly influenced by eco-phenomenological thought, and by his decade-long personal practice with Buddhism and Shamanism. He is currently focused on scaling opportunities for flourishing, well-being, and transformation through the synthesis of contemplative practices, immersive technology, and psychedelics.

Links:

Timestamps:

  • :05 - Martijn’s style of leadership
  • :14 - The value of having a comprehensive, integrated team at Synthesis
  • :19 - Ketamine vs psilocybin and the value of a communal setting for healing
  • :23 - How Synthesis creates a healing “container”
  • :30 - Integration, evidence-based care, and post retreat risks
  • :38 - Comprehensive medical screening protocols
  • :46 - The stewardship model as the future of psychedelic business
  • 1:00 - Advice to psychedelic therapists

Jun 18 2021

1hr 4mins

Play

Hanifa Nayo Washington & Adam Rubin (Fireside Project): The Psychedelic Peer Support Hotline

Podcast cover
Read more

A difficult psychedelic experience once meant a hospital visit… or worse. Now, in the spirit of the Zendo Project and other psychedelic peer support organizations, we have a new hotline called the Fireside Project (call or text 62-FIRESIDE) and there’s a lot that psychedelic therapists can learn from leaders like Hanifa Nayo Washington and Adam Rubin.

On the show, we discuss the influence of ceremonial medicine and legacy psychedelic support organizations in informing Fireside. We talk about the value of community in mental health and how Fireside nurtures their own cohort of volunteers. We review the data from the first 18 days of operation and discuss potential legal issues. Finally as always, Hanifa and Adam share their advice to psychedelic therapists.

Fireside Project Co-founder, Adam Rubin is a psychedelic harm reduction activist and crisis counselor. He has worked over 45 events around the world since 2015 with many different organizations including the Zendo Project, White Bird Rock Med, RGX Medical, and Take 3 Presents. He has given trainings to peer support volunteers, local psychedelic communities, and event medical teams. He has also written a series of zines titled “The It’s Okay Psychedelic Harm Reduction Series” and distributes them for free.

Hanifa Nayo Washington is Fireside Project’s Cultivator Of Beloved Community. She is an award-winning cultural producer and the Principal Organizer & Co-Founding Practitioner of One Village Healing, a wellness and resilience initiative. Hanifa has been combining arts, healing, and activism to make the world a better place for 20+ years and in 2017 she released her 3rd album Mantras for the Revolution. In December 2018 Hanifa received a Phenomenal Women Arts Award from the Arts Council of Greater New Haven for her contributions and achievements in the arts.

Links

Timestamps

  • :04 - Hanifa’s background in ceremonial psychedelic medicine and community building
  • :13 - Adam’s experience with Zendo Project and other psychedelic peer support groups
  • :17 - Psychedelic peer support is not shamanism
  • :21 - The value of holding space in community and the challenges with doing that over a phone line.
  • :30 - How Fireside supports their beloved community of volunteers
  • :41 - Skills earned in psychedelic peer support
  • :45 - Data collected by Fireside
  • :50 - The legal status of organizations like Fireside
  • :58 - Advice to psychedelic therapists

Jun 10 2021

1hr 9mins

Play

Justin Townsend (MycoMeditations): The Many Modalities of Mushroom Retreats

Podcast cover
Read more

There are only a few places in the world which offer legal access to high impact psilocybin retreats. MycoMeditations, stewarded by today’s guest Justin Townsend, is leading the way in sustainable, ethical psychedelic healing that takes into account the unique environment and needs of Jamaica and its people.

On the show, we discuss Jungian-depth psychology and other therapeutic modalities used at MycoMeditations. We talk about the value of a comprehensive, holistic team of caregivers for cathartic experiences. We review the efficacy of psilocybin as compared to ketamine therapy and ayahuasca ceremonies. Finally, we discuss the landscape of psychedelic healing in Jamaica and the importance of ethical entheogenic businesses.

MycoMeditations is a retreat that combines the powerful healing of multiple, high-dose psilocybin experiences, a safe and caring group environment created by a knowledgeable support staff, and serene locations to catalyze life-changing transformations.

As a business leader and startup advisor in a range of industries including the health care space, Justin Townsend has also been on a personal quest to explore alternative healing therapies to combat his own anxiety and depression. Over the past 20 years, Justin has delved into both transpersonal and Jungian psychology, explored psychedelic modes of healing and developed meditation and breath work techniques, which he taught in Germany. Justin joined the MycoMeditations team in 2017, becoming partner and CEO in 2019. As a retreat facilitator, Justin draws inspiration from the profound healing he is privileged to witness and believes that psychedelics offer an exciting path forward for mental health.

Links

Timestamps

  • :05 - Justin’s introduction to psychedelics
  • :10 - Jungian depth psychology and psychedelic healing
  • :16 - Comprehensive support team at MycoMeditations
  • :23 - The efficacy psilocybin vs ketamine or ayahuasca for depression treatment
  • :30 - The most effective psychological modalities when working with psilocybin
  • :38 - The landscape of psychedelics in Jamaica
  • :48 - Advice to therapists wishing to work in the mushroom space.

May 11 2021

1hr

Play

Sydney Bergen & Noemi Toth: A Patient's Experience With Ketamine Therapy

Podcast cover
Read more

Today on the Psychedelic Therapy Podcast, for the first time, we are discussing a firsthand account of a patient’s experience of psychedelic therapy. Sydney Bergen received six ketamine infusions administered by Noemi Toth. On the show Sydney and Noemi share their experience working together.

The conversation starts with Noemi’s work with the Aspen Ketamine Center and Sydney’s reasons for pursuing psychedelic therapy. We talk about ketamine’s safety as a dissociative anesthetic and the subjective experience of that dissociation. Sydney and Noemi both emphasize the importance of integration therapy after treatment, including in Sydney’s case, Internal Family Systems therapy. Finally, we end the show with lessons and suggestions for potential ketamine infusion patients.

Sydney is an Emotional Clearing Facilitator, dedicated to her own healing journey and to supporting others by sharing her story.

Noemi has been practicing as a Nurse Anesthesiologist since 2010. She has performed hundreds of ketamine infusions over the last four years and helps people overcome depression and anxiety disorders.

The Aspen Ketamine Clinic, located in Aspen Colorado, takes a multi-disciplinary approach towards mental health. In addition to resources mentioned on the show, this includes nutritional counseling and bio-identical hormone therapy as options for treatment through their network of specialists. You can learn more at https://www.ketaminevida.com/

LINKS

TIMESTAMPS

  • :04 - Noemi’s experience founding Aspen Ketamine Clinic
  • :12 - Ketamine’s safety as an office procedure
  • :22 - The subjective experience of dissociation
  • :29 - Sydney’s use of Internal Family Systems therapy particularly for the integration piece.
  • :39 - The post infusion process and integration therapy
  • :49 - Lessons and suggestions for those interested in receiving ketamine assisted therapy

Apr 19 2021

59mins

Play

Dr. Steven Mandel & Sam Mandel: The Efficacy of Ketamine Infusion Therapy

Podcast cover
Read more

A hot topic in the world of psychedelic medicine is whether ketamine infusion therapy is as effective as ketamine-assisted therapy (also called KAP). Today’s guests Dr. Steven Mandel and his son Sam Mandel have administered over 13,000 treatments at their Los Angeles-based clinic and they are passionate about the power of intravenous ketamine treatment.

On the show we discuss the efficacy of IV ketamine therapy and how it compares to intramuscular as a route of administration. We talk about Dr. Mandel’s specific protocol including the use of a pump instead of a drip bag for administration. We cover the potential health concerns around ketamine and finish as always with advice to psychedelic therapists.

Dr. Steven Mandel has more than 40 years of experience utilizing ketamine as a board-certified anesthesiologist and has a master’s degree in psychology. He is the co-founder and president of Ketamine Clinics Los Angeles, and the co-founder of American Society of Ketamine Physicians, Psychotherapists and Practitioners.

Sam Mandel is co-founder and chief operating officer of Ketamine Clinics Los Angeles. A mental health advocate and entrepreneur, he oversees all non-clinical functions of the company and has been active in the ketamine infusion therapy community since its formative days.

LINKS

TIMESTAMPS

  • :05 - How Dr. Mendel and his son Sam started the Ketamine Clinics of Los Angeles
  • :09 - Should psychedelic practitioners receive the treatment themselves?
  • :16 - How ketamine functions in the brain
  • :23 - Is ketamine infusion therapy as effective as psychedelic-assisted talk therapy?
  • :32 - Intervenus vs Intramuscular ketamine
  • :39 - Dr. Mandel’s ketamine protocol
  • :46 - How do you assess the effectiveness of ketamine therapy?
  • :54 - Potential issues with ketamine use: addiction, bladder damage, or cognitive impairment.
  • 1:08 - Dr. Steven and Sam Mandel share their advice

Apr 02 2021

1hr 12mins

Play

Mendel Kaelen (Wavepaths): The Science of Psychedelics & Sound

Podcast cover
Read more

From reggae and cannabis to the icaros of an Ayahuasca ceremony, sound has a huge impact on altered states of consciousness, but what’s actually going on scientifically and how can we use this to improve the outcomes of psychedelic therapy? Today’s guest, Mendel Kaelen founder of Wavepaths, has researched the subject extensively.

On the show, we discuss how music and psychedelics reinforce each other exponentially. We talk about the importance of “tone color” and other aspects of structured sound for the experience of healing. Mendel shares about his creation Wavepaths, which he considers more of a musical instrument than software. Finally we explore traditional Ayahuasca icaros, the scared songs of the Amazon.

Mendel is the founder and CEO of Wavepaths, a company that is researching the psychotherapeutic potential of music and creating a tool for therapists. Mendel was also a PhD and postdoctoral neuroscientist at Imperial College London, where among other research, he investigated the role of music in psychedelic therapies.

Links

Timestamps

  • :08 - Mendel’s first experience with psychedelics and their impact on his life
  • :16 - An empirical foundation for why music and psychedelics together reinforce each other in an exponential way
  • :23 - The impact of “tone color” in the psychedelic experience
  • :32 - Music for psychedelic therapy must be fitting to what an individual has built an identity structure around
  • :39 - Wavepaths is more a musical instrument than a software but it’s not about whether or not you “like” the music
  • :50 - Traditional Ayahuasca music “icaros”
  • 1:02 - Mendel speaks to psychedelic therapists

Mar 12 2021

1hr 9mins

Play

Joseph Barsuglia: Is 5-MeO-DMT the Future of Psychedelic Medicine?

Podcast cover
Read more

What if you could have a more potent mystical experience than psilocybin in a quarter of the time? 5-MeO-DMT could be the future of psychedelic medicine, but as Dr. Joseph Barsuglia explains, this would require a complete redesign of our current model of care.

On the show, we discuss the nature of mystical experiences as well as our current understanding of the science of 5-MeO-DMT. Joseph reveals some of the drug development companies interested in medicalization as well as his concerns about this process. We finish with the environmental considerations for the bufo alvarious toad and lessons this medicine has for the psychedelic movement.

Joseph is a PhD neuropsychologist and the former Director of Clinical Assessment and Research at Crossroads Treatment Center which developed a protocol following ibogaine with 5-MeO-DMT. Trained with MAPS and initiated in the Bwiti tradition in Gabon, Joseph advises on psychedelic medicine and alternative healthcare.

Links

Timestamps

  • :05 - The protocol of ibogaine + 5-MeO-DMT at Crossroads Treatment Center
  • :13 - The nature of mystical experiences
  • :20 - The science of 5-MeO-DMT
  • :24 - Specific drug development companies working with 5-MeO
  • :33 - Concerns about the medicalization of 5-MeO-DMT
  • :38 - The Conclave, a group of anonymous facilitators offer best practices and integration guides for 5-MeO online
  • :46 - Environmental concerns for bufo alvarious
  • :57 - Lessons from 5-MeO-DMT for the psychedelic movement generally

Feb 26 2021

1hr 11mins

Play

Rachel Yehuda (Mount Sinai): Studying the Science of Psychedelics and PTSD

Podcast cover
Read more

Today’s guest is a legend in the field of traumatic stress studies. Dr. Rachel Yehuda has been researching stress and PTSD for 30 years and now with the promising results from MDMA clinical trials trials, she and her team have founded the Mount Sinai Psychedelic Psychotherapy and Trauma Research.

On the show, we discuss the four pillars of Mount Sinai’s new center. We go deep into the history of the PTSD diagnosis and the evolving understanding of how trauma works in the brain, including an explanation of epigenetics. We look at how the center will study psychedelic medicine from basic science using stem cells to specific types of therapy, and collaboration with other medical centers.

Dr. Yehuda is the Director of the Center for Psychedelic Psychotherapy and Trauma Research at Mount Sinai, Vice Chair for Veterans Affairs for the Department of Psychiatry, Director of the Traumatic Stress Studies Division, Director of the Yehuda Lab, and a Professor of Psychiatry and Neuroscience at the Icahn School of Medicine. She is also the Director of Mental Health at the James J. Peters VA Medical Center. She has authored more than 450 published papers, chapters, and books in the field of trauma and resilience, focusing on topics such as PTSD prevention and treatment, molecular biomarkers of stress vulnerability and resilience, and intergenerational effects of trauma and PTSD.

Links

Timestamps

  • :05 - Rachel explains the four pillars of the new Mount Sinai Psychedelic Psychotherapy and Trauma Research
  • :09 - Rachel explains what PTSD is and her experience of the field of trauma studies
  • :21 - How epigenetics, the study of gene expression, holds the key to PTSD
  • :30 - How the Center will study psychedelics
  • :39 - Using stem cells to study the efficacy of different psychedelic molecules
  • :44 - Biomedical approach verses studying the efficacy of particular therapies
  • :52 - The Center’s approach to collaboration

Feb 20 2021

1hr 6mins

Play

Charlotte James & Undrea Wright (The Sabina Project): Living Ceremony

Podcast cover
Read more

When ancestral wisdom is missing from modern psychedelic conversations, the Black-led Sabina Project is there to educate, reduce harm, and facilitate ceremony. On today’s episode of the Psychedelic Therapy Podcast, Charlotte James and Undrea Wright invite us to reconnect to Sacred Earth Medicines.

We begin the show discussing Kambo, a healing ritual using the poisonous secretions of the giant monkey frog. We talk about why it is so necessary to connect to ancestral wisdom in the modern psychedelic movement through the lens of the project’s upcoming series AfroPsychedelia. Charlotte and Dre share how the Sabina Project has shifted to facilitate remote and legal ceremonies with Rapeh (also called hapè), an Amazonian medicinal snuff. Overall, Dre and Charlotte embody the Sabina Project mission of teaching others how to live life in ceremony.

Charlotte James and Undrea Wright are cofounders of the Sabina Project, named after María Sabina, a Mazateca curandera. The Sabina Project focuses on providing psychedelic education particular for the BIPOC community, as well as preparation and integration and the facilitation of legal ceremonies. Charlotte has a background in harm reduction, psychedelic exploration, and marketing strategy. Undrea is a Kambo medicine practitioner and cannabis entrepreneur involved in decriminalization efforts. Together they utilize ancient earth medicines and ancestral wisdom to support equitable liberation and spiritual enlightenment.

Links:

Timestamps:

  • :04 - Charlotte and Undrea’s backgrounds and their connection at the People of Color Psychedelics Conference
  • :09 - Dre and Charlotte explain Kambo
  • :16 - The story of Maria Sabina, the namesake of the Sabina Project
  • :21 - Ancestral wisdom, the Bwiti and Sabina’s event AfroPsychedelia
  • :27 - Organizations going a good job with equity and access
  • :33 - How the Sabina Project educates by helping people prepare to live their life in ceremony
  • :43 - How the Sabina Project supports remote ceremony
  • :53 - Undrea and Charlotte speak directly to psychedelic practitioners

Feb 12 2021

1hr 2mins

Play

Andrea Jungaberle (The MIND Foundation): Evidence-Based Psychedelic Healthcare in Germany

Podcast cover
Read more

If there was ever a people who understand the importance of evidence-based healthcare, it’s the Germans, and they are starting to get very interested in psychedelic medicine. Today our guest is Dr. Andrea Jungaberle, co-founder of the MIND Foundation, a research center and nonprofit advocacy group for psychedelics in Berlin.

On the show we discuss the current landscape of psychedelic-assisted therapy in Germany. Andrea shares about the importance of evidence-based care and the forthcoming 144 person psilocybin study EPIsoDe on which the MIND Foundation is a collaborating partner. She details MINDS’ Augmented Psychotherapy Program and Insight Conference. Finally Andrea speaks about her book “Yoga, Tea, and LSD,” and her passion for using psychedelics to work with end-of-life anxiety.

Andrea is a co-founder and board member of the MIND Foundation. She also serves as OVID Health Systems’ Medical Director and MIND’s Director of Collaboration and Media. She is a clinical specialist in anesthesia and emergency medicine and currently training in cognitive behavioral psychotherapy. She is a certified Kundalini Yoga teacher, has participated in several accredited trainings in psychedelic therapy, and is part of the EPIsoDe study team, preparing to treat patients at Charité hospital in Germany’s first modern clinical trial involving psilocybin.

Links

Timestamps

  • :04 - Andrea’s journey from inquisitive child to leading a psychedelic foundation
  • :13 - The landscape in Germany for psychedelic-assisted therapy
  • :17 - Evidence-based care and the EPIsoDe teams 144 person psilocybin study
  • :26 - How psychedelic healthcare is beginning to be accepted in mainstream medicine in Germany
  • :32 - The Mind Foundation’s Augmented Psychotherapy Program focuses on the science of classic psychedelics, breath work, and ketamine assisted therapy.
  • :38 - The Insight Conference focusing on new ideas in psychedelics that conform to the scientific worldview
  • :42 - Andrea’s book “Yoga, Tea, and LSD” and her interest in psychedelics and death

Feb 04 2021

1hr 1min

Play

Genesee Herzberg (Sage Institute): How to Build an Ethical Psychedelic Clinic

Podcast cover
Read more

Equal access to psychedelic medicine is a huge issue in this burgeoning field. Today’s guest, Genesee Herzberg has prioritized ethics in founding Sage Institute, a sliding scale clinic that offers psychotherapy and psychedelic-assisted therapy and is also supporting the proliferation of ethical clinics through a new consulting group, Forth Road Health.

On the show, we discuss how Sage Institute uses the community mental health clinic model to provide greater access to psychedelic-assisted therapy. We talk about Sage’s protocols as well as its training and research components. We discuss the efficacy of different molecules for treatment as well as the psycholytic vs psychedelic approach to Ketamine-assisted therapy. Finally we discuss Forth Road, a forthcoming Strategic Consulting Company, that supports academic medical institutions, healthcare systems, independent practitioners and therapy providers exploring psychedelic-assisted therapy.

Genesee is an individual, couple and family therapist. She trained in MDMA-assisted therapy for PTSD with MAPS and Ketamine-assisted therapy with the KRIYA Institute. She is the co-founder and Executive Director of both Sage Integrative Health, and Sage Institute both located in the California Bay Area.

This podcast is brought to you by Maya, a software platform designed to help psychedelic practitioners manage, measure, and illustrate health outcomes We are currently working with Ketamine practitioners, including today’s guests Genesee, in the development of the platform through our Council of Guides. If you are interested in being a part of this group, helping to co-create the Maya platform, please visit: bit.ly/mayacouncil

Notes

Timestamps

  • :04 - Genesee’s early interest in psychedelics and her world with CIIS.
  • :13 - The Sage Institute nonprofit business model and efforts to promote accessibility for psychedelic medicine
  • :21 - Sage Institute’s training and research components
  • :24 - Ketamine vs MDMA vs psilocybin and psycholytic approach vs the psychedelic approach
  • :31 - The Sage protocol for ketamine-assisted therapy
  • :35 - Forth Road support for folks starting their own independent clinics
  • :48 - Genesee speaks directly to psychedelics practitioners

Jan 27 2021

53mins

Play

Aaron Paul Orsini & Justine Lee: Autism, LSD, and Appreciating Neurodiversity

Podcast cover
Read more

Can psychedelics be considered a “neurological contact lens” for those on the Autism spectrum? Today’s guests Aaron Paul Orsini and Justine Lee are determined to find out and are sharing their findings with the world.

On the podcast, we discuss how experimenting with LSD helped Aaron understand and appreciate his Autism as a kind of altered state and led to his book Autism on Acid. We cover seven key takeaways for using psychedelics to work with autistic populations. Justine shares how connectivity works in neurodiverse brains. Finally we talk about the weekly gathering, the Autistic Psychedelic Community, and how psychedelic therapists can get involved.

Aaron and Justine are cofounders of the Autistic Psychedelic Community, a peer support group for neurodivergent individuals interested in discussing psychedelics. Aaron is the author of Autism On Acid: How LSD Helped Me Understand, Navigate, Alter & Appreciate My Autistic Perceptions and is currently editing his second book, a neurodiversity-minded anthology of psychedelic essays that is now available for preorder. Justine is a graduate student in pharmacology at University of California, Irvine. She is investigating the therapeutic potential of psychedelic compounds with respect to autism and other neurological conditions.

Links

Timestamps

  • :04 - How experimenting with LSD awakened Aaron to interoception and led to him writing the book Autism on Acid
  • :16 - What is Autism and how does that express for Aaron
  • :24 - 7 Essential takeaways for using psychedelics to work with autistic populations
  • :39 - Justine describes the connectivity in neurodiverse brains
  • :46 - Aaron suggests a peer-supported retreat or ceremony model for working with autistic populations with psychedelics
  • :57 - The Autistic Psychedelic Community and how psychedelic practitioners can get involved
  • 1:09 - Aaron and Justine speak directly to psychedelic practitioners

Jan 19 2021

1hr 13mins

Play

Thank You Psychedelic Practitioners: A 2020 Retrospective

Podcast cover
Read more

While 2020 has been difficult in so many ways, this year brought psychedelic medicine further ahead by leaps and bounds. At Maya, we were honored to share the wisdom of 25 healers and leaders in the psychedelic world through this podcast. Today we are sharing their advice to practitioners.

On the show, our guests offer advice and perspectives to the therapists doing this important work. Their wisdom is at times simple, profound, and even controversial or contradictory. They speak of how to approach clients of specific demographics, how therapists might relate to themselves in this work, and what our collective responsibility is to the psychedelic movement as a whole. Most of all, across the board, our guests have expressed their gratitude. Thank you, thank you, thank you, psychedelic therapists!

You can hear more from each of our guests in a full episode at mayahealth.com/podcast.

Timestamps

  • :02 - David Rabin
  • :07 - Irina Alexander
  • :09 - Tony Moss
  • :11 - Erica Siegal
  • :13 - Dick Schwartz
  • :14 - Akoni Anthony
  • :18 - Maria Theresa Chavez
  • :20 - Charles Flores
  • :24 - Kevin Franciotti
  • :25 - Bia Labate
  • :29 - Lauren Taus
  • :31 - Bessel van der Kolk
  • :33 - Jesse Gould
  • :34 - Florie St. Aime
  • :37 - Belinda Eriacho
  • :39 - Lynn Marie Morisky
  • :41 - Deanne Adamson
  • :47 - Veronika Gold
  • :49 - Jessica Cadoch
  • :51 - Darragh Stewart
  • :52 - Ronan Levy
  • :53 - Jonathan de Potter
  • :56 - Molly Maloof
  • 1:00 - Jonathan Sabbagh

Dec 31 2020

1hr 1min

Play

Jonathan Sabbagh (Journey): Supporting Independent Psychedelic Practitioners

Podcast cover
Read more

Jonathan Sabbagh is building a space and solution for independent therapists who want to provide Ketamine-assisted psychotherapy (KAP) by offering a prescription service, a medically supervised location, and a community.

On the show, we talk about Jonathan’s startup Journey and the tools he is creating to democratize access for independent psychedelic practitioners. We discuss set and setting and the Journey space. We talk about vetting and training psychedelic therapist and how Journey endeavors can create community. We also go over concerns around the medicalization of psychedelics.

Jonathan is the Co-founder and CEO of Journey Clinical Inc and is currently studying to be a psychedelic therapist himself at The New School. After 20 years in finance and entrepreneurship, he is bringing his skills and passion into the psychedelic community with the support of his own deep medicine work.

As the adoption of psychedelic therapy grows worldwide, support services for independent practitioners, like Journey, will be invaluable.

Links

Timestamps

  • :03 - How Jonathan went from working in finance to going to school to become a psychedelic therapist
  • :11 - How Journey is creating the spaces and tools for independent psychedelic therapists to thrive.
  • :18 - The set and setting of the Journey space will be designed as a crystal
  • :23 - Therapist vetting and training
  • :28- Democratizing access for independent practitioners
  • :31 - Concerns about the medicalization of psychedelic medicine
  • :42 - How Journey plans to foster community for psychedelic practitioners

Dec 21 2020

49mins

Play

Molly Maloof MD: Dr. Molly’s Ketamine Protocol

Podcast cover
Read more

Today on the podcast, I'm speaking to Dr. Molly Maloof, a concierge and lifestyle medicine practitioner who has developed a comprehensive protocol for Ketamine-assisted therapy.

On the show, we talk about Molly’s professional journey from burning out in residency to concierge medicine to Stanford professor and Ketamine practitioner. We discuss her protocol in detail and why one shouldn’t try to treat their own depression with street Ketamine. Finally, Dr. Molly gives her advice to new practitioners especially regarding creating a brand in the psychedelic space.

Dr. Molly is a physician, an entrepreneur a medical advisor, a Ketamine practitioner, and a Stanford lecturer. She has advised over 42 companies throughout the world and has lectured extensively. You can catch her with Dr. David Rabin on the Psychedelic News Hour on Fridays on ClubHouse or in the Apple Store as a podcast in January.

Healing is holistic, and it seems like Dr. Molly has thought of everything.

NOTES

TIMESTAMPS

  • :07 - Dr. Molly’s first experience with psychedelics and her professional journey
  • :23 - Incorporating spirituality into a medical practice
  • :30 - Dr. Molly’s ketamine protocol
  • :41 - Why shouldn’t people use street ketamine to treat their own depression?
  • :48 - Dr Molly’s advice to upcoming practitioners
  • :53 - Providing equal access to psychedelic medicine and other issues and opportunities in the Psychedelic Renaissance

Dec 14 2020

1hr 5mins

Play

Jonathan De Potter (Behold Retreats): Bringing Plant Medicine to Asia

Podcast cover
Read more

Today on the he Psychedelic Therapy Podcast I’m speaking to a man who is changing the narrative around plant medicine in Asia. Jonathan de Potter, founder of Behold Retreats has big visions for the region and it starts with helping business leaders awaken.

On the show, we talk about the challenges of addressing mental health issues in Asia. Jonathan shares his perspective of what makes a great psychedelic practitioner from his own experiences. We discuss Behold Retreats and why Jonathan is focusing on healing leaders in the business world. We also review medical screening and onboarding of patients. Finally Jonathan shares his predictions for the future of plant medicine in Asia.

Prior to launching Behold Retreats in March, Jonathan directed business strategy for Accenture in Hong Kong. His personal experience with plant medicine radically altered the course of his life, and he spent 5 years working with medicine before launching his retreat company. Behold has held retreats in Mexico, Ecuador, and Costa Rica, and is planning to expand to Peru, the Netherlands, Portugal, and Spain.

Before we get started, a word from Maya, the platform designed to help psychedelic practitioners track, measure, and illustrate the health outcomes of their work and the organization that makes this podcast possible.

Maya is currently working with individual ketamine practitioners in its pilot program called the Council of Guides. If you are interested in being a part of this group, helping to co-create the Maya platform and getting first access, please visit the Council of Guides page on the Maya website at https://www.mayahealth.com/council.

LINKS

TIMESTAMPS

  • :06 - How Jonathan is changing the narrative about plant medicine in Asia
  • :13 - How does a westerner bridge the gap around psychedelics and mental health in Asia
  • :21 - What makes a great psychedelic partitioner
  • :25 - The structure of Behold Retreats and why Jonathan focuses on clients from the business world
  • :31 - How Jonathan tracks the impact his retreats are having in the world.
  • :36 - Medical screening and patient onboarding at Behold Retreats
  • :48 - Jonathan’s predictions for plant medicine in Asia.

Dec 04 2020

59mins

Play

Ronan Levy (Field Trip): The Promise and Peril of Industrialized Psychedelics

Podcast cover
Read more

Today I’m interviewing Ronan Levy, co-founder of the psychedelic healthcare company Field Trip. The company includes Field Trip Health Centers for ketamine-assisted therapy, Field Trip Digital (including the apps Trip and Portal), and Field Trip Discovery, which amongst other pursuits is developing the novel psychedelic FT - 104.

On the show we talk about Ronan’s experiences with psychedelics and meditation and the business of Field Trip in detail. Ronan shares his perspective on the modernization and industrialization of psychedelics and addresses the concerns of the existing psychedelic community on the impact of big business on the community. We also talk about the role of therapists, equal access to medicine, and whether it would be a good thing to get mental health benefits without the trip.

As one of a few large organizations hoping to industrialize psychedelic medicine, Field Trip is controversial within the psychedelic community. While Maya Health and I personally don’t endorse all aspects of the Field Trip model, Ronan is a thoughtful person and was gracious in inviting a nuanced conversation about these issues. During the interview, we discuss the North Star psychedelic ethics pledge, of which Maya is a signatory, and the cautionary fable We Will Call It Pala about unforeseen consequences in the rush to psychedelic medicalization, which I would recommend reading prior to listening to this conversation.

Ronan is the Co-founder and Executive Chairman of Field Trip. He is also a partner at Grassfed Ventures, a cannabis and biotech VC firm, and Chief Strategy Officer for Trait Biosciences. He co-founded Canadian Cannabis Clinics as well as CanvasRx Inc. Originally a lawyer, Ronan holds a Juris Doctor and Bachelor of Commerce degree from the University of Toronto. You can hear Ronan on The Field Tripping Podcast, a place for epic personal, spiritual and business journeys on — and in — psychedelics.

Links

Timestamps:

  • :05 - Ronan’s describes his first experience with psychedelics and his meditation practice
  • :12 - Ronan describes Field Trip Health Centers and Field Trip Digital
  • :19 - Ronan describes Field Trip Discovery, including the development of a novel psychedelic molecule called FT-104
  • :23 - Ronan shares his perspective on the industrialization and corporatization of psychedelics and Field Trip’s place in that process
  • :33 - How Field Trip approaches the therapists who work at their clinic
  • :37 - Field Trip has not signed the North Star psychedelic ethics pledge but they did apply for B-Corp status
  • :44 - I suggest Ronan get input for Field Trip by sitting in a traditional ayahuasca ceremony
  • :51 - Would it be good thing to get mental health benefits without the trip?
  • :58 - The question of equal access to psychedelics
  • 1:08 - Ronan speak to psychedelic therapists

Nov 13 2020

1hr 13mins

Play

Darragh Stewart (Inwardbound): My Psychedelic Irish Brother

Podcast cover
Read more

Before today’s conversation I didn’t know much about Celtic Shamanism.

Today’s guest, Darragh Stewart is a shining beacon of knowledge and joy. As a PhD in plant molecular biology, he has gone all in on plant medicine to support his psychedelic Irish brothers and everyone else who needs to break through the blockages in their lives.

On the show, we talk about how Darragh blends science and spirituality. We get into the origin and structure of Inwardbound Psychedelic Retreats, which take place legally in the Netherlands. We talk about Darragh’s passion for men’s work including the integration group he co-founded called the "Psychedelic Brothers of Ireland." Finally, we get into Celtic Shamanism and efforts to heal the broken lineage of holistic and ancestral healing in Ireland.

One important note: At Inwardbound, all clients go through a strict pre-screening process. In order to attend the retreats, participants cannot have a diagnosed psychiatric illness such as schizophrenia, bipolar, clinical depression or a personality disorder. Similarly, Inwardbound is not able to  accommodate participants dealing with serious addiction, substance abuse issues, or who have a personal or family history of psychosis. If this is the case for you, it is recommended that you apply for a clinical research trial.

Links

Timestamps

  • :06 - How Darragh came to plant medicine from a scientific background
  • :14 - The origin and structure of Inward Bound retreats
  • :27 - Men's work with the Psychedelic Brothers of Ireland
  • :33 - Typical male wounds that come up in psychedelic healing
  • :41 - Celtic Shamanism and healing broken lineages on the Emerald Isle.
  • :55 - Darragh speaks to psychedelic therapists

Oct 30 2020

1hr 1min

Play

iTunes Ratings

5 Ratings
Average Ratings
5
0
0
0
0

Love this content

By Sam Osborn - May 13 2020
Read more
So helpful to hear smart perspectives at each phase along the spiritual journey :)